Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2016

01-04-2016 | Original Article

Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett’s Esophagus in Adults

Authors: Seiji Shiota, Hashem B. El-Serag, Aaron P. Thrift

Published in: Digestive Diseases and Sciences | Issue 4/2016

Login to get access

Abstract

Background

Birth characteristics, including weight and gestational age, may be associated with risk of Barrett’s esophagus (BE), the only known precursor for esophageal adenocarcinoma; however, data are limited.

Aims

To examine associations between various birth characteristics and BE, and whether these associations are mediated by known risk factors for BE.

Methods

Data were obtained from a cross-sectional study among eligible Veterans Affairs patients scheduled for an upper endoscopy, and a sample identified from primary care clinics. Participants underwent an esophagogastroduodenoscopy and completed a survey that captured information on sociodemographic and clinical factors, as well as birth information. We compared 263 patients with histologically confirmed BE to 1416 controls without BE on endoscopy. Odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated using multivariate logistic regression.

Results

Premature birth was independently associated with risk of BE after adjusted by age, sex, race, and other birth characteristics (OR 3.28, 95 % CI 1.22–8.79). On the other hand, large for gestational age was inversely associated with risk of BE (OR 0.46, 95 % CI 0.21–0.98). These effects were stronger for patients with long-segment BE than with short-segment BE. The associations were not mediated by gastroesophageal reflux disease symptoms, use of proton pump inhibitors, Helicobacter Pylori infection, waist-hip-ratio, height or the presence of hiatus hernia.

Conclusions

Premature birth and large for gestational age may be associated with risk of BE in adults. These associations do not appear to be mediated through known risk factors for BE; however, additional studies are required to confirm our findings.
Appendix
Available only for authorised users
Literature
2.
go back to reference Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012;23:3155–3162.CrossRefPubMed Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012;23:3155–3162.CrossRefPubMed
5.
go back to reference Wang KK, Sampliner RE. The practice parameters committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–797.CrossRefPubMed Wang KK, Sampliner RE. The practice parameters committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–797.CrossRefPubMed
6.
go back to reference Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett’s esophagus. Gastroenterology. 2010;138:854–869.CrossRefPubMedPubMedCentral Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett’s esophagus. Gastroenterology. 2010;138:854–869.CrossRefPubMedPubMedCentral
7.
go back to reference Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365:1375–1383.CrossRefPubMed Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365:1375–1383.CrossRefPubMed
8.
go back to reference Corley DA, Mehtani K, Quesenberry C, Zhao W, de Boer J, Weiss NS. Impact of endoscopic surveillance on mortality from Barrett’s esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013;145:312–9e1.PubMed Corley DA, Mehtani K, Quesenberry C, Zhao W, de Boer J, Weiss NS. Impact of endoscopic surveillance on mortality from Barrett’s esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013;145:312–9e1.PubMed
9.
go back to reference Bhat SK, McManus DT, Coleman HG, et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett’s oesophagus: a population-based study. Gut. 2015;64:20–25.CrossRefPubMed Bhat SK, McManus DT, Coleman HG, et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett’s oesophagus: a population-based study. Gut. 2015;64:20–25.CrossRefPubMed
10.
go back to reference Whiteman DC. Does a prior diagnosis of Barrett’s oesophagus influence risk of dying from oesophageal adenocarcinoma? Gut. 2015;64:5–6.CrossRefPubMed Whiteman DC. Does a prior diagnosis of Barrett’s oesophagus influence risk of dying from oesophageal adenocarcinoma? Gut. 2015;64:5–6.CrossRefPubMed
11.
go back to reference Verbeek RE, Leenders M, Ten Kate FJ, et al. Surveillance of Barrett’s esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study. Am J Gastroenterol. 2014;109:1215–1222.CrossRefPubMed Verbeek RE, Leenders M, Ten Kate FJ, et al. Surveillance of Barrett’s esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study. Am J Gastroenterol. 2014;109:1215–1222.CrossRefPubMed
12.
go back to reference Ekbom A. Growing evidence that several human cancers may originate in utero. Semin Cancer Biol. 1998;8:237–244.CrossRefPubMed Ekbom A. Growing evidence that several human cancers may originate in utero. Semin Cancer Biol. 1998;8:237–244.CrossRefPubMed
13.
go back to reference McCormack VA, dos Santos Silva I, Koupil I, Leon DA, Lithell HO. Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer. 2005;115:611–617.CrossRefPubMed McCormack VA, dos Santos Silva I, Koupil I, Leon DA, Lithell HO. Birth characteristics and adult cancer incidence: Swedish cohort of over 11,000 men and women. Int J Cancer. 2005;115:611–617.CrossRefPubMed
14.
15.
go back to reference Ahlgren M, Sorensen T, Wohlfahrt J, Haflidadottir A, Holst C, Melbye M. Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer. 2003;107:997–1000.CrossRefPubMed Ahlgren M, Sorensen T, Wohlfahrt J, Haflidadottir A, Holst C, Melbye M. Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer. 2003;107:997–1000.CrossRefPubMed
16.
go back to reference Ahlgren M, Wohlfahrt J, Olsen LW, Sorensen TI, Melbye M. Birth weight and risk of cancer. Cancer. 2007;110:412–419.CrossRefPubMed Ahlgren M, Wohlfahrt J, Olsen LW, Sorensen TI, Melbye M. Birth weight and risk of cancer. Cancer. 2007;110:412–419.CrossRefPubMed
17.
go back to reference Kaijser M, Akre O, Cnattingius S, Ekbom A. Preterm birth, low birth weight, and risk for esophageal adenocarcinoma. Gastroenterology. 2005;128:607–609.CrossRefPubMed Kaijser M, Akre O, Cnattingius S, Ekbom A. Preterm birth, low birth weight, and risk for esophageal adenocarcinoma. Gastroenterology. 2005;128:607–609.CrossRefPubMed
18.
go back to reference Akre O, Forssell L, Kaijser M, et al. Perinatal risk factors for cancer of the esophagus and gastric cardia: a nested case–control study. Cancer Epidemiol Biomarkers Prev. 2006;15:867–871.CrossRefPubMed Akre O, Forssell L, Kaijser M, et al. Perinatal risk factors for cancer of the esophagus and gastric cardia: a nested case–control study. Cancer Epidemiol Biomarkers Prev. 2006;15:867–871.CrossRefPubMed
19.
go back to reference Forssell L, Cnattingius S, Bottai M, et al. Risk of oesophageal adenocarcinoma among individuals born preterm or small for gestational age. Eur J Cancer. 2013;49:2207–2213.CrossRefPubMed Forssell L, Cnattingius S, Bottai M, et al. Risk of oesophageal adenocarcinoma among individuals born preterm or small for gestational age. Eur J Cancer. 2013;49:2207–2213.CrossRefPubMed
20.
go back to reference Forssell L, Cnattingius S, Bottai M, et al. Increased risk of Barrett’s esophagus among individuals born preterm or small for gestational age. Clin Gastroenterol Hepatol. 2013;11:790–794.CrossRefPubMed Forssell L, Cnattingius S, Bottai M, et al. Increased risk of Barrett’s esophagus among individuals born preterm or small for gestational age. Clin Gastroenterol Hepatol. 2013;11:790–794.CrossRefPubMed
21.
go back to reference Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB. Age at onset of GERD symptoms predicts risk of Barrett’s esophagus. Am J Gastroenterol. 2013;108:915–922.CrossRefPubMedPubMedCentral Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB. Age at onset of GERD symptoms predicts risk of Barrett’s esophagus. Am J Gastroenterol. 2013;108:915–922.CrossRefPubMedPubMedCentral
22.
go back to reference Thrift AP, Risch HA, Onstad L, et al. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by mendelian randomization. Clin Gastroenterol Hepatol. 2014;12:1667–1676.CrossRefPubMedPubMedCentral Thrift AP, Risch HA, Onstad L, et al. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by mendelian randomization. Clin Gastroenterol Hepatol. 2014;12:1667–1676.CrossRefPubMedPubMedCentral
23.
go back to reference Thrift AP, Shaheen NJ, Gammon MD, et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a mendelian randomization study. J Natl Cancer Inst. 2014;106:dju252. doi:10.1093/jnci/dju252. Thrift AP, Shaheen NJ, Gammon MD, et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a mendelian randomization study. J Natl Cancer Inst. 2014;106:dju252. doi:10.​1093/​jnci/​dju252.
24.
go back to reference Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1399–1412.CrossRefPubMed Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11:1399–1412.CrossRefPubMed
25.
go back to reference Nguyen TH, Thrift AP, Ramsey D, et al. Risk factors for Barrett’s esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014;109:1870–1880.CrossRefPubMed Nguyen TH, Thrift AP, Ramsey D, et al. Risk factors for Barrett’s esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014;109:1870–1880.CrossRefPubMed
26.
go back to reference Kramer JR, Fischbach LA, Richardson P, et al. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett’s esophagus in white men. Clin Gastroenterol Hepatol. 2013;11:373–381.CrossRefPubMedPubMedCentral Kramer JR, Fischbach LA, Richardson P, et al. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett’s esophagus in white men. Clin Gastroenterol Hepatol. 2013;11:373–381.CrossRefPubMedPubMedCentral
27.
go back to reference Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.CrossRefPubMed Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–1399.CrossRefPubMed
28.
go back to reference Armstrong D, Bennett J, Blum A, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92.CrossRefPubMed Armstrong D, Bennett J, Blum A, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92.CrossRefPubMed
29.
go back to reference Talge NM, Mudd LM, Sikorskii A, Basso O. United States birth weight reference corrected for implausible gestational age estimates. Pediatrics. 2014;133:844–853.CrossRefPubMed Talge NM, Mudd LM, Sikorskii A, Basso O. United States birth weight reference corrected for implausible gestational age estimates. Pediatrics. 2014;133:844–853.CrossRefPubMed
30.
go back to reference Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359:61–73.CrossRefPubMedPubMedCentral Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359:61–73.CrossRefPubMedPubMedCentral
31.
go back to reference Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;1:1077–1081.CrossRefPubMed Barker DJ, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;1:1077–1081.CrossRefPubMed
32.
33.
go back to reference Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD. Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet. 1996;348:1478–1480.CrossRefPubMed Frankel S, Elwood P, Sweetnam P, Yarnell J, Smith GD. Birthweight, body-mass index in middle age, and incident coronary heart disease. Lancet. 1996;348:1478–1480.CrossRefPubMed
34.
go back to reference Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med. 2004;351:2179–2186.CrossRefPubMed Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. N Engl J Med. 2004;351:2179–2186.CrossRefPubMed
35.
go back to reference Johnsson IW, Haglund B, Ahlsson F, Gustafsson J. A high birth weight is associated with increased risk of type 2 diabetes and obesity. Pediatr Obes. 2015;10:77–83.CrossRefPubMed Johnsson IW, Haglund B, Ahlsson F, Gustafsson J. A high birth weight is associated with increased risk of type 2 diabetes and obesity. Pediatr Obes. 2015;10:77–83.CrossRefPubMed
36.
go back to reference Poets CF. Gastroesophageal reflux: a critical review of its role in preterm infants. Pediatrics. 2004;113:e128–e132.CrossRefPubMed Poets CF. Gastroesophageal reflux: a critical review of its role in preterm infants. Pediatrics. 2004;113:e128–e132.CrossRefPubMed
37.
39.
go back to reference Dhillon AS, Ewer AK. Diagnosis and management of gastro-oesophageal reflux in preterm infants in neonatal intensive care units. Acta Paediatr. 2004;93:88–93.CrossRefPubMed Dhillon AS, Ewer AK. Diagnosis and management of gastro-oesophageal reflux in preterm infants in neonatal intensive care units. Acta Paediatr. 2004;93:88–93.CrossRefPubMed
40.
go back to reference Omari TI, Barnett CP, Benninga MA, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut. 2002;51:475–479.CrossRefPubMedPubMedCentral Omari TI, Barnett CP, Benninga MA, et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut. 2002;51:475–479.CrossRefPubMedPubMedCentral
41.
go back to reference Peter CS, Wiechers C, Bohnhorst B, Silny J, Poets CF. Influence of nasogastric tubes on gastroesophageal reflux in preterm infants: a multiple intraluminal impedance study. J Pediatr. 2002;141:277–279.CrossRefPubMed Peter CS, Wiechers C, Bohnhorst B, Silny J, Poets CF. Influence of nasogastric tubes on gastroesophageal reflux in preterm infants: a multiple intraluminal impedance study. J Pediatr. 2002;141:277–279.CrossRefPubMed
42.
go back to reference Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ. Congenital malformations and intrauterine growth retardation: a population study. Pediatrics. 1988;82:83–90.PubMed Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ. Congenital malformations and intrauterine growth retardation: a population study. Pediatrics. 1988;82:83–90.PubMed
43.
go back to reference Tsai J, Blinman TA, Collins JL, et al. The contribution of hiatal hernia to severe gastroesophageal reflux disease in patients with gastroschisis. J Pediatr Surg. 2014;49:395–398.CrossRefPubMed Tsai J, Blinman TA, Collins JL, et al. The contribution of hiatal hernia to severe gastroesophageal reflux disease in patients with gastroschisis. J Pediatr Surg. 2014;49:395–398.CrossRefPubMed
44.
go back to reference Rubenstein JH, Thrift AP. Risk factors and populations at risk: selection of patients for screening for Barrett’s oesophagus. Best Pract Res Clin Gastroenterol. 2015;29:41–50.CrossRefPubMed Rubenstein JH, Thrift AP. Risk factors and populations at risk: selection of patients for screening for Barrett’s oesophagus. Best Pract Res Clin Gastroenterol. 2015;29:41–50.CrossRefPubMed
45.
go back to reference Thrift AP, Garcia JM, El-Serag HB. A multibiomarker risk score helps predict risk for Barrett’s esophagus. Clin Gastroenterol Hepatol. 2014;12:1267–1271.CrossRefPubMedPubMedCentral Thrift AP, Garcia JM, El-Serag HB. A multibiomarker risk score helps predict risk for Barrett’s esophagus. Clin Gastroenterol Hepatol. 2014;12:1267–1271.CrossRefPubMedPubMedCentral
46.
go back to reference Kemp M, Gunnell D, Maynard M, Smith GD, Frankel S. How accurate is self reported birth weight among the elderly? J Epidemiol Community Health. 2000;54:639.CrossRefPubMedPubMedCentral Kemp M, Gunnell D, Maynard M, Smith GD, Frankel S. How accurate is self reported birth weight among the elderly? J Epidemiol Community Health. 2000;54:639.CrossRefPubMedPubMedCentral
Metadata
Title
Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett’s Esophagus in Adults
Authors
Seiji Shiota
Hashem B. El-Serag
Aaron P. Thrift
Publication date
01-04-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3967-3

Other articles of this Issue 4/2016

Digestive Diseases and Sciences 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.